Pharmacology and Toxicology
Welcome to the Department of Pharmacology and Toxicology at the Medical College of Wisconsin is dedicated to quality in research, graduate and postdoctoral training and medical education. The research interests of our faculty are broadly based in cardiovascular pharmacology, neuropharmacology, cancer pharmacology, toxicology and molecular pharmacology. The research programs in the Department of Pharmacology and Toxicology are also multidisciplinary in nature and have strong associations with researchers of other basic science and clinical departments. Read more...
John D. Imig, PhD
Professor, Pharmacology and Toxicology
Can a research laboratory make major breakthroughs and develop novel therapeutics for cardiovascular and kidney diseases? The answer is a resounding, YES!
Dr. Imig’s research has focused on a class of fatty acids, arachidonic acid metabolites that have been targeted by drugs for the treatment of pain, fever, blood clotting, and asthma. Utilizing animal models of cardiovascular and kidney diseases his laboratory has demonstrated that arachidonic acid metabolites called epoxyeicosatrienoic acids (EETs) and the enzyme soluble epoxide hydrolase are not properly regulated during disease states. Over the past decade his laboratory was a major driving force in the development of drugs that inhibit the soluble epoxide hydrolase enzyme and one of these drugs is currently being tested in humans for the treatment of chronic obstructive pulmonary disease (COPD). More recently, the laboratory has focused on developing EET-based drugs for the treatment of hypertension, acute renal failure, and chronic kidney disease. These novel small molecule EET analogs are demonstrating great potential and could one day in the near future be used to treat cardiovascular and kidney diseases in humans.
Earn a graduate degree from Pharmacology and Toxicology
Our graduate degree program includes dynamically changing disciplines such as neuropharmacology and molecular pharmacology. This program receives many students from the Interdisciplinary Program of Neuroscience and Biomedical Science.
Pharmacology & Toxicology Headlines
7/9/15: Chris Olsen, PhD and Scott Levick, PhD named recipients of inaugural Presidential Faculty Scholar Awards.
4/26/15: Chris Olsen, PhD, discussed concussions and substance abuse on Radio 620 WTMJ Weekend Morning News.
11/17/14: Terri deRoon-Cassini, PhD and Cecilia Hillard, PhD, investigate biological factors of post-traumatic stress disorder.
9/24/14: Carol Williams, PhD Ridin' to a Cure.
9/17/14: Cecilia Hillard, PhD, treating post traumatic stress disorder.
6/30/2014: Qing-Song Liu, PhD is exploring new methods to fight drug addiction with a new 5 year, 1.6 million NIH grant.
6/24/2014: Cecilia Hillard's, PhD new grant Drug Addiction: What Causes Relapse?
3/13/2014: Rock River Cancer Research Foundation awards $75,000 to Carol Williams, PhD.
2/25/2014: Founding Director of the Neuroscience Research Center, Cecilia Hillard, PhD, announces gift for neuroscience research from BMO Harris Bank.
2/4/2014: Abdul Hye Khan, was selected as a winner of the 2014 APS Renal Section Research Recognition Award.
Archived Pharmacology Headlines
Please wait while we gather your results.
Other Pharmacology and Toxicology News
July 16 - Kathryn M. “Kathy” Gauthier, PhD, associate professor of pharmacology and toxicology, died Monday, July 13. She was 60 years old.
July 14 - John Imig, PhD provides expert comment on the identification of a key mechanism in neuropathic pain by scientists at the University of California, Davis. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage. UC-Davis
July 13 - John Imig, PhD, (Pharmacology & Toxicology) tells International Business Times that he expects the debut of the PCSK-9 inhibitors (which targets a mutation in the PCSK-9 gene, which causes high cholesterol) will spur companies to invest in this area as scientists continue their search for genetic factors underlying major diseases. International Business Times
May 6 - Carol Williams, PhD, (Pharmacology & Toxicology) received a five-year, $1.75 million grant from the National Cancer Institute to study a new approach at limiting the spread of breast cancer. Dr. Williams will repurpose existing medications that target a family of molecules suspected in the spread of breast cancer. The medications are not currently used to treat cancers. Health Canal
Please wait while we gather your results.
Calendar EventsNo events were found matching your criteria.